4-[8-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-[1]benzofuro[2,3-b]pyridin-2-yl]benzonitrile
C37H30N4O — CID 171051864
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[8-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-[1]benzofuro[2,3-b]pyridin-2-yl]benzonitrile
4-[8-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-[1]benzofuro[2,3-b]pyridin-2-yl]benzonitrile (PubChem CID 171051864) has the molecular formula C37H30N4O and a molecular weight of 546.67 g/mol. Its IUPAC name is 4-[8-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-[1]benzofuro[2,3-b]pyridin-2-yl]benzonitrile.
Molecular Properties
| Compound Name | 4-[8-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-[1]benzofuro[2,3-b]pyridin-2-yl]benzonitrile |
|---|---|
| PubChem CID | 171051864 |
| Molecular Formula | C37H30N4O |
| Molecular Weight | 546.67 g/mol |
| Exact Mass | 546.24 |
| IUPAC Name | 4-[8-[1-[2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-[1]benzofuro[2,3-b]pyridin-2-yl]benzonitrile |
| SMILES | CC(C)c1cccc(C(C)C)c1-n1c(-c2cccc3c2oc2nc(-c4ccc(C#N)cc4)ccc23)nc2ccccc21 |
| InChI | InChI=1S/C37H30N4O/c1-22(2)26-9-7-10-27(23(3)4)34(26)41-33-14-6-5-13-32(33)39-36(41)30-12-8-11-28-29-19-20-31(40-37(29)42-35(28)30)25-17-15-24(21-38)16-18-25/h5-20,22-23H,1-4H3 |
| InChIKey | ZEZHQBURLVWRLR-UHFFFAOYSA-N |
| XLogP | 9.77 |
| TPSA | 67.64 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 546.67 |
| LogP ≤ 5 | 9.77 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171051864 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.